Abstract
Glioblastoma multiforme (GBM) is a fast-growing and aggressive brain tumor that has a complicated diagnosis and is hard to treat, presenting a poor long-term prognosis. Conventional treatments, including surgery, radiation therapy, and chemotherapy with temozolomide (TMZ), face limitations, primarily attributed to the blood-brain barrier (BBB) hindering therapeutics delivery. Emerging cel…